{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.110.12.1086",
  "meta" : {
    "versionId" : "10",
    "lastUpdated" : "2022-03-02T18:03:48.000-05:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086",
  "version" : "20190315",
  "name" : "Hib Vaccine (4 dose schedule) Administered",
  "status" : "active",
  "date" : "2022-03-03T18:46:01-05:00",
  "publisher" : "NCQA PHEMUR",
  "compose" : {
    "include" : [{
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155"]
    },
    {
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157"]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:8255cdce-2db2-4715-bc2b-c5edc1be04a8",
    "timestamp" : "2022-09-27T21:23:52-04:00",
    "total" : 11,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "310306005",
      "display" : "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "310307001",
      "display" : "Administration of second dose of Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "310308006",
      "display" : "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "312870000",
      "display" : "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "414001002",
      "display" : "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "414259000",
      "display" : "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "415507003",
      "display" : "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://snomed.info/sct",
      "version" : "http://snomed.info/sct/731000124108/version/20220301",
      "code" : "415712004",
      "display" : "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
    },
    {
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "90644",
      "display" : "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
    },
    {
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "90648",
      "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
    },
    {
      "system" : "http://www.ama-assn.org/go/cpt",
      "version" : "2022",
      "code" : "90698",
      "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
    }]
  }
}